Chinese tech giant Baidu (NASDAQ:BIDU) said on Wednesday that an algorithm created by the company was able to boost the antibody response of a COVID-19 vaccine more than 100 times. In a study published in Nature, Baidu (BIDU) researchers said the AI algorithm, known as LinearDesign, was able to create "highly stable" messenger RNA sequences for the vaccines and ultimately boost the efficacy of the vaccines by 128 times. In an email to Seeking Alpha, a Baidu (BIDU) spokesman said the design capabilities of LinearDesign could be applied to other vaccines and treatments in the future. The COVID-19 enhancement from…